Active substance
Hyoscine butylbromide
- SFDA 20
- Health Canada 5
- NHS prices 3
- WHO EML 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| BUSCOPAN TABLETS 10MG | 10 mg | Tablet · Oral use | 20 Blister | SAR 14.00 | NCE · OTC | A. Nattermann and Cie Gmbh | Valid |
| DEFOPAN 5MG-5ML SYRUP | 1 mg/ml | Syrup · Oral use | 1 Bottle | SAR 10.80 | Generic · OTC | DEEF PHARMACEUTICAL INDUSTRIES | Valid |
| HYOPAN SYRUP 5 MG-5 ML | 1 mg/ml | Syrup · Oral use | 1 Bottle | SAR 10.80 | Generic · OTC | KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES | Valid |
| Hyponal | 20 mg/ml | Solution for injection · Intramuscular and intravenous use | 5 Ampoule | SAR 8.45 | Generic · Prescription | Egyptian International Pharmaceutical Industries Company (EIPICO) | Valid |
| NOSPASM 10 MG TAB | 10 mg | Tablet · Oral use | 30 Blister | SAR 16.25 | Generic · OTC | SPIMACO ADDWAEIH | Valid |
| SCOPINAL 20MG AMPOULE | 20 mg | Solution for injection · Intravenous use | 5 Ampoule | SAR 12.70 | Generic · Prescription | Gulf Pharmaceutical Industries (Julphar) | Valid |
| SCOPINAL 5MG-5ML SYRUP | 1 mg/ml | Syrup · Oral use | 1 Bottle | SAR 10.80 | Generic · OTC | Gulf Pharmaceutical Industries (Julphar) | Valid |
| SCOPINAL TAB 10MG | 10 mg | Film-coated tablet · Oral use | 20 Blister | SAR 7.40 | Generic · OTC | Gulf Pharmaceutical Industries (Julphar) | Valid |
| SPASMOPAN 10MG TAB. | 10 mg | Tablet · Oral use | 20 Blister | SAR 7.40 | Generic · OTC | THE ARAB PHARMACEUTICAL MANUFACTURING PSC - Sult | Valid |
| SPASMOPAN 20MG AMP. | 20 mg/ml | Injection · Intravenous use | 5 Ampoule | SAR 12.70 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
| Spasmopan | 10 mg | Coated tablet · Oral use | 1000 Blister | SAR 158.80 | Generic · OTC | THE ARAB PHARMACEUTICAL MANUFACTURING COMPANY | Valid |
| BUSCOPAN TABLETS 10MG | 10 mg | Tablet · Oral use | 20 Blister | SAR 11.65 | NCE · OTC | BOEHRINGER INGELHEIM | Withdrawn by MAH · Not Marketed |
| HOLOPON TAB 1MG | 1 mg | Tablet · Oral use | 20 Tablet Container | SAR 8.65 | Generic · OTC | NYCOMED | Withdrawn by MAH · Not Marketed |
| HYOBAN 10MG F.C TABLET | 10 mg | Film-coated tablet · Oral use | 30 Blister | SAR 9.20 | Generic · OTC | Tabuk Pharmaceutical Manufacturing Company | Withdrawn by MAH · Not Marketed |
| RIASPASM | 1 mg/ml | Syrup · Oral use | 1 Bottle | SAR 7.30 | Generic · OTC | RIYADH PHARMA | Withdrawn by MAH · Not Marketed |
| RIASPASM 10 mg film-coated tablet | 10 mg | Film-coated tablet · Oral use | 20 Blister | SAR 6.80 | Generic · OTC | RIYADH PHARMA | Withdrawn by MAH · Not Marketed |
| SPASMO- H 10MG FILM COATED TABLETS | 10 mg | Film-coated tablet · Oral use | 20 Blister | SAR 4.60 | Generic · OTC | SHAPHACO PHARMACEUTICAL | Invalid · Not Marketed |
| SPASMONORE SUPP.ADULT | 10 mg | Suppository · Rectal use | 5 Blister | SAR 1.70 | NCE · Prescription | The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM) | Withdrawn by MAH · Not Marketed |
| SPASMONORE SUPP.CHILD 7.5MG | 7.5 mg | Suppository · Rectal use | 5 Blister | SAR 1.40 | NCE · Prescription | The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM) | Withdrawn by MAH · Not Marketed |
| SPASMONORE TAB 10MG | 10 mg | Tablet · Oral use | 30 Blister | SAR 3.15 | Generic · OTC | The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM) | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ABDOMINAL SPASM; ANESTHESIA-SUPPORTIVE AGENTS/ INHIBITION OF SALIVARY GLAND AND RESPIRATORY TRACT SECRETIONS; IRRITABLE BOWEL SYNDROME
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| ACCEL-HYOSCINE | 02512335 | 10 MG | TABLET · ORAL | ACCEL PHARMA INC |
| BUSCOPAN | 00363812 | 10 MG | TABLET · ORAL | SANOFI CONSUMER HEALTH INC |
| BUSCOPAN | 00363839 | 20 MG / ML | SOLUTION · SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR | SANOFI CONSUMER HEALTH INC |
| HYOSCINE BUTYLBROMIDE INJECTION | 02229868 | 20 MG / ML | SOLUTION · INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS | SANDOZ CANADA INCORPORATED |
| HYOSCINE BUTYLBROMIDE INJECTION BP | 02508419 | 20 MG / ML | SOLUTION · SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR | OMEGA LABORATORIES LIMITED |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Hyoscine butylbromide 10mg tablets | £6.53 | 56 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Hyoscine butylbromide 20mg tablets | £15.95 | 100 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Hyoscine butylbromide 20mg/1ml solution for injection ampoules | £4.19 | 10 ampoule | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 2.3. Medicines for other common symptoms in palliative care · core
Palliative care
Parenteral > General injections > unspecified: 20 mg per mL injection
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.